Señales en vivo de IBRX | Maximiza tus Ganancias con Getagraph.com

COMPRAR 106668 min ago

@ $4.52

Emitido: 14 feb 2024 @ 13:58

Retorno: 62.79%

Señal anterior: feb 14 - 09:30

Señal anterior: Vender

Retorno: 4.24 %

Live Chart Being Loaded With Signals

Commentary (26 abr 2024 @ 16:00):

Stats
Volumen de hoy	39.08M
Volumen promedio	5.40M
Capitalización de mercado	4.95B
EPS	$-0.350 ( 2024-03-20 )
Próxima fecha de ganancias	( $-0.160 ) 2024-05-09
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-6.39
ATR14	$0.117 (1.59%)

Insider Trading

Date	Person	Action	Amount	type
2024-02-22	Simon Barry J.	Buy	159 146	Stock Option (right to buy)
2024-02-22	Simon Barry J.	Buy	45 731	Restricted Stock Units
2024-02-22	Lauer Regan J	Buy	42 439	Stock Option (right to buy)
2024-02-22	Lauer Regan J	Buy	12 195	Restricted Stock Units
2024-02-22	Sachs David C.	Buy	424 390	Stock Option (right to buy)

INSIDER POWER
99.24
Last 97 transactions
Buy: 228 380 025 \| Sell: 921 083

Volumen Correlación

Largo: 0.53 (weak)

Corto: -0.15 (neutral)

Signal:(48.073) Neutral

ImmunityBio, Inc. Correlación

10 Correlaciones Más Positivas
SIRI	0.928
RGF	0.928
FGBI	0.925
AROW	0.921
ALRS	0.92
GNTY	0.92
CBNK	0.915
GSMG	0.914
GOOD	0.906
ALLK	0.906

10 Correlaciones Más Negativas
RIVE	-0.933
DSEY	-0.93
DUOL	-0.927
AMPH	-0.926
RAM	-0.919
INTA	-0.919
PLYA	-0.918
ALTR	-0.91
DAIO	-0.909
MLTX	-0.907

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

ImmunityBio, Inc. Correlación - Moneda/Commodity

0.51
( weak )

0.64
( weak )

0.00
( neutral )

0.23
( neutral )

0.04
( neutral )

0.83
( strong )

ImmunityBio, Inc. Finanzas

Annual	2023
Ingresos:	$622 000
Beneficio Bruto:	$-17.89M (-2 876.21 %)
EPS:	$-1.150

FY	2023
Ingresos:	$622 000
Beneficio Bruto:	$-17.89M (-2 876.21 %)
EPS:	$-1.150

FY	2022
Ingresos:	$240 000
Beneficio Bruto:	$-23.95M (-9 980.00 %)
EPS:	$-1.040

FY	2021
Ingresos:	$934 000
Beneficio Bruto:	$0.00 (0.00 %)
EPS:	$-0.893

Financial Reports:

No articles found.

ImmunityBio, Inc.

ImmunityBio, Inc., a clinical-stage biotechnology company, develops therapies and vaccines to treat cancers and infectious diseases. It offers immunotherapy and cell therapy platforms, including antibody cytokine fusion proteins, synthetic immunomodulators, vaccine technologies, natural killer cells, and adaptive (T cell) immune systems. The company also develops therapeutic agents, which are in Phase II or III clinical trial for the treatment of liquid and solid tumors, including bladder, pancreatic, and lung cancers, as well as pathogens as SARS-CoV-2 and HIV. It has collaboration agreements with National Cancer Institute, National Institute of Deafness and Communication Disorders, and Amyris, Inc.; and license agreements with CytRx Corporation, EnGeneIC Pty Limited, GlobeImmune, Inc., and Infectious Disease Research Institute, Sanford Health, Shenzhen Beike Biotechnology Co. Ltd., Sorrento Therapeutics, Inc., and Viracta Therapeutics, Inc. The company was founded in 2014 and is based in San Diego, California.